Related Experiment Video
Updated: Apr 27, 2026

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
Published on: February 16, 2011
Defining Value in Cancer Care: AVBCC 2012 Steering Committee Report
, Gene Beed1, Gary M Owens2
1President and CEO, Horses, Zebras, and Unicorns, Irvine, CA.
The Association for Value-Based Cancer Care (AVBCC) conference convened stakeholders to define value in cancer care. Discussions focused on strategies to improve patient outcomes while managing costs through collaborative approaches.
Area of Science:
- Oncology
- Healthcare Management
- Health Economics
Background:
- The Second Annual Conference of the Association for Value-Based Cancer Care (AVBCC) addressed the need to define value in cancer care.
- Healthcare stakeholders convened to discuss challenges and opportunities in optimizing oncology value.
Purpose of the Study:
- To align diverse stakeholder perspectives on defining and implementing value in cancer care.
- To identify strategies for enhancing patient outcomes while controlling costs in oncology.
Main Methods:
- A conference format featuring over 20 sessions and symposia led by oncology leaders.
- A Steering Committee discussion with 11 panel members to define value and propose action steps.
Main Results:
- Discussions focused on current trends and challenges in optimizing oncology value.
- Exploration of emerging management approaches and tools for collaborative cancer care enhancement.
- Articulation of action steps for implementing value-based cancer care delivery.
Conclusions:
- Defining value in cancer care requires alignment among various stakeholders.
- Strategies to improve care quality and patient outcomes while managing costs are crucial.
- Collaborative tools and approaches are emerging to enhance cancer care value.
More Related Videos
07:47Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
Published on: December 15, 2023
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
Related Concept Videos
Patient-centered Care
Standards of Care II
Standards of Care I
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies